Macro and Micro Level Usage of Outcomes Research in Pharmacy Practices.
作者信息
Rasu Rafia S
出版信息
Hosp Pharm. 2016 May;51(5):351-2. doi: 10.1310/hpj5105-351.
Abstract
摘要
相似文献
1
Macro and Micro Level Usage of Outcomes Research in Pharmacy Practices.
Hosp Pharm. 2016 May;51(5):351-2. doi: 10.1310/hpj5105-351.
2
Investigating influences on current community pharmacy practice at micro, meso, and macro levels.
Res Social Adm Pharm. 2017 Jul-Aug;13(4):727-737. doi: 10.1016/j.sapharm.2016.06.007. Epub 2016 Jul 21.
3
Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
Rural Remote Health. 2021 Jul;21(3):6158. doi: 10.22605/RRH6158. Epub 2021 Jul 26.
4
The emergence of social order in everyday interacting: re-conceptualizing a venerable sociological concept in light of conversation analysis.
Front Sociol. 2023 Nov 27;8:1102449. doi: 10.3389/fsoc.2023.1102449. eCollection 2023.
5
An ethnographic exploration of influences on prescribing in general practice: why is there variation in prescribing practices?
Implement Sci. 2013 Jun 21;8:72. doi: 10.1186/1748-5908-8-72.
6
Modeling the micro-macro link: Understanding macro-level outcomes using randomization tests on micro-level data.
Soc Sci Res. 2019 Jan;77:79-87. doi: 10.1016/j.ssresearch.2018.08.013. Epub 2018 Sep 4.
7
Patient-reported symptom monitoring: using (big) data to improve supportive care at the macro-, meso-, and micro-levels.
Support Care Cancer. 2024 Feb 22;32(3):182. doi: 10.1007/s00520-024-08373-x.
8
Research on Continuous Error Compensation of a Sub-Arc-Second Macro/Micro Dual-Drive Rotary System.
Micromachines (Basel). 2022 Oct 2;13(10):1662. doi: 10.3390/mi13101662.
9
Quantifying causal emergence shows that macro can beat micro.
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19790-5. doi: 10.1073/pnas.1314922110. Epub 2013 Nov 18.
10
Macro-Micro Simulation for Polymer Crystallization in Couette Flow.
Polymers (Basel). 2017 Dec 11;9(12):699. doi: 10.3390/polym9120699.
本文引用的文献
1
Design, implementation, and first-year outcomes of a value-based drug formulary.
J Manag Care Spec Pharm. 2015 Apr;21(4):269-75. doi: 10.18553/jmcp.2015.21.4.269.
2
An updated method for risk adjustment in outcomes research.
Value Health. 2014 Jul;17(5):629-33. doi: 10.1016/j.jval.2014.05.003. Epub 2014 Jun 23.
3
Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality.
J Am Pharm Assoc (2003). 2014 May-Jun;54(3):228-40. doi: 10.1331/JAPhA.2014.13180.
4
Communicating and promoting comparative-effectiveness research findings.
N Engl J Med. 2013 Jul 18;369(3):209-11. doi: 10.1056/NEJMp1300312.
5
Anticonvulsant use after formulary status change for brand-name second-generation anticonvulsants.
Am J Manag Care. 2010 Aug;16(8):e197-204.
6
Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I.
Value Health. 2009 Nov-Dec;12(8):1044-52. doi: 10.1111/j.1524-4733.2009.00600.x. Epub 2009 Sep 29.
7
Comparative effectiveness research: Relevance and applications to pharmacy.
Am J Health Syst Pharm. 2009 Jul 15;66(14):1278-86. doi: 10.2146/ajhp090150.
8
Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Int J Technol Assess Health Care. 2008 Summer;24(3):244-58; discussion 362-8. doi: 10.1017/S0266462308080343.
Zotero 插件